Voyager Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.About VYGR
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01.
CEOAlfred W. Sandrock
CEOAlfred W. Sandrock
Employees172
Employees172
HeadquartersLexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded2013
Founded2013
Employees172
Employees172
VYGR Key Statistics
Market cap180.67M
Market cap180.67M
Price-Earnings ratio-2.11
Price-Earnings ratio-2.11
Dividend yield—
Dividend yield—
Average volume651.38K
Average volume651.38K
High today$3.32
High today$3.32
Low today$3.08
Low today$3.08
Open price$3.15
Open price$3.15
Volume620.42K
Volume620.42K
52 Week high$9.55
52 Week high$9.55
52 Week low$2.65
52 Week low$2.65
VYGR News
TipRanks 6d
Voyager Therapeutics’ Promising Alzheimer’s Study: A Potential Game-Changer?Voyager Therapeutics Inc. ((VYGR)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium...
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own VYGR. This list is generated using Robinhood data, and it’s not a recommendation.